Dr. Mohammed Hamid, MD

NPI: 1063942589
Total Payments
$44,404
2024 Payments
$43,863
Companies
10
Transactions
30
Medicare Patients
469
Medicare Billing
$68,888

Payment Breakdown by Category

Other$43,777 (98.6%)
Food & Beverage$627.45 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Grant $43,777 1 98.6%
Food and Beverage $627.45 29 1.4%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $43,835 5 $0 (2024)
ABBVIE INC. $195.95 11 $0 (2024)
NOVARTIS PHARMACEUTICALS CORPORATION $153.03 1 $0 (2023)
Otsuka America Pharmaceutical, Inc. $109.26 7 $0 (2018)
Sandoz Inc. $23.18 1 $0 (2024)
Janssen Biotech, Inc. $22.60 1 $0 (2023)
Amgen Inc. $19.29 1 $0 (2018)
ConvaTec Inc. $17.90 1 $0 (2018)
AstraZeneca Pharmaceuticals LP $16.68 1 $0 (2018)
Cumberland Pharmaceuticals, Inc. $11.51 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $43,863 5 PFIZER INC. ($43,788)
2023 $280.93 8 NOVARTIS PHARMACEUTICALS CORPORATION ($153.03)
2022 $85.75 6 ABBVIE INC. ($73.81)
2018 $120.74 8 Otsuka America Pharmaceutical, Inc. ($55.36)
2017 $53.90 3 Otsuka America Pharmaceutical, Inc. ($53.90)

All Payment Transactions

30 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
07/01/2024 PFIZER INC. Grant Cash or cash equivalent $43,776.76 General
02/20/2024 ABBVIE INC. HUMIRA (Biological), RINVOQ Food and Beverage In-kind items and services $25.68 General
Category: IMMUNOLOGY
02/14/2024 Sandoz Inc. HYRIMOZ (Biological) Food and Beverage In-kind items and services $23.18 General
Category: Immunology
01/26/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $11.68 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
01/18/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $25.59 General
Category: IMMUNOLOGY
11/12/2023 NOVARTIS PHARMACEUTICALS CORPORATION Food and Beverage In-kind items and services $153.03 General
10/06/2023 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $18.62 General
Category: IMMUNOLOGY
09/13/2023 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $22.60 General
Category: Immunology
08/12/2023 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $15.98 General
Category: IMMUNOLOGY
07/28/2023 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $22.36 General
Category: IMMUNOLOGY
07/21/2023 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $18.91 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
03/31/2023 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $13.91 General
Category: IMMUNOLOGY
02/24/2023 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $15.52 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/09/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $12.73 General
Category: IMMUNOLOGY
12/02/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $11.94 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/19/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $17.01 General
Category: IMMUNOLOGY
10/15/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $16.73 General
Category: IMMUNOLOGY
10/01/2022 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $14.13 General
Category: IMMUNOLOGY
07/22/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $13.21 General
Category: IMMUNOLOGY
12/13/2018 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $16.68 General
Category: Cardiovascular and Metabolism
12/06/2018 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Food and Beverage In-kind items and services $11.33 General
Category: NEPHROLOGY
08/28/2018 ConvaTec Inc. AQUACEL AG (Device), AQUACEL Food and Beverage Cash or cash equivalent $17.90 General
Category: WOUND THERAPEUTICS
08/22/2018 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $12.41 General
Category: NEPHROLOGY
08/02/2018 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Food and Beverage In-kind items and services $15.33 General
Category: NEPHROLOGY
04/23/2018 Cumberland Pharmaceuticals, Inc. Caldolor (Drug) Food and Beverage In-kind items and services $11.51 General
Category: Anesthesiology (Pain Management)

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 3 59 59 $82,885 $8,890
2021 6 325 331 $435,145 $46,481
2020 3 85 85 $120,870 $13,517
Total Patients
469
Total Services
475
Medicare Billing
$68,888
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 29 29 $40,584 $4,226 10.4%
99291 Critical care, first 30-74 minutes Facility 2022 16 16 $24,759 $2,685 10.8%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 14 14 $17,542 $1,979 11.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 112 112 $161,224 $17,441 10.8%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 58 61 $96,851 $10,643 11.0%
99220 Hospital observation care, typically 70 minutes Facility 2021 78 80 $105,513 $10,620 10.1%
99219 Hospital observation care, typically 50 minutes Facility 2021 46 46 $44,376 $4,776 10.8%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 15 15 $14,583 $1,613 11.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 16 17 $12,599 $1,388 11.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 37 37 $53,262 $5,889 11.1%
99220 Hospital observation care, typically 70 minutes Facility 2020 32 32 $42,205 $4,753 11.3%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 16 16 $25,404 $2,875 11.3%

About Dr. Mohammed Hamid, MD

Dr. Mohammed Hamid, MD is a Internal Medicine healthcare provider based in Caldwell, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2017. The National Provider Identifier (NPI) number assigned to this provider is 1063942589.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Hamid, MD has received a total of $44,404 in payments from pharmaceutical and medical device companies, with $43,863 received in 2024. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "Grant" ($43,777).

As a Medicare-enrolled provider, Hamid has provided services to 469 Medicare beneficiaries, totaling 475 services with total Medicare billing of $68,888. Data is available for 3 years (2020–2022), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Caldwell, NJ
  • Active Since 06/18/2017
  • Last Updated 12/31/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1063942589

Products in Payments

  • RINVOQ (Biological) $156.14
  • SAMSCA (Drug) $96.85
  • XELJANZ (Drug) $58.05
  • HUMIRA (Biological) $25.68
  • HYRIMOZ (Biological) $23.18
  • TREMFYA (Drug) $22.60
  • AQUACEL AG (Device) $17.90
  • BRILINTA (Drug) $16.68
  • SKYRIZI (Biological) $14.13
  • JYNARQUE (Drug) $12.41
  • Caldolor (Drug) $11.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Caldwell